4//SEC Filing
MABVAX THERAPEUTICS HOLDINGS, INC. 4
Accession 0001415889-17-000635
CIK 0001109196operating
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 6:31 PM ET
Size
8.9 KB
Accession
0001415889-17-000635
Insider Transaction Report
Form 4
HANSON GREGORY P
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-04-07$2.00/sh−450$902→ 33,691 total - Sale
Common Stock
2017-04-10$2.00/sh−400$800→ 33,291 total - Sale
Common Stock
2017-04-11$2.00/sh−200$400→ 33,091 total
Footnotes (2)
- [F1]Represents a portion of the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II of the reporting person's Form 4, as filed with the Securities and Exchange Commission on April 4, 2017. This sale is mandated by the Issuer's election under the equity incentive plan to require satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2 to $2.01 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001109196
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 6:31 PM ET
- Size
- 8.9 KB